Inhibition by the cysteine peptidase inhibitor E64d and related inhibitor CA‐074Me (which preferentially inhibits intracellular CatB) reduces brain Aβ peptide levels and improves memory in an AD mouse model. This evidence concerns the gene TYRP1 and Alzheimer disease.